Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective-Reference-Cited by-同舟云学术

Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective

Published:2010-03-26 Issue:3 Volume:3 Page:173-177
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Shale Matt¹,Czub Markus²,Kaplan Gilaad G.³,Panaccione Remo³,Ghosh Subrata⁴

Affiliation:

1. Gastrointestinal Section, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom

2. Virology and Emerging Infectious Diseases Faculty of Medicine University of Calgary 3330 Hospital Drive NW Calgary, AB, Canada T2N 4N1

3. Division of Gastroenterology, Department of Medicine, Faculty of Medicine, University of Calgary, TRW Centre, 3280 Hospital Drive NW, Calgary, AB, Canada T2N 4Z6

4. Division of Gastroenterology, Professor of Medicine, Division of Gastroenterology, TRW Centre, 3280 Hospital Drive NW, Calgary, AB, Canada T2N 4Z6,

Abstract

The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gives a scientific perspective to this issue including the role of vaccination.

Publisher

SAGE Publications

Subject

Gastroenterology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756283X10366368

Reference38 articles.

1. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs;Rheumatology and Therapy;2022-12-17

2. Targeting ectromelia virus and TNF/NF-κB or STAT3 signaling for effective treatment of viral pneumonia;Proceedings of the National Academy of Sciences;2022-02-17

3. Mast cells in severe respiratory virus infections: insights for treatment and vaccine administration;AIMS Allergy and Immunology;2022

4. TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study;Rheumatology and Therapy;2021-07-23

5. Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection;Frontiers in Cellular and Infection Microbiology;2021-02-19